Fu Xiaorui, Shang Yufeng, Zhang Lei, Li Ling, Li Xin, Wang Xinhua, Sun Zhenchang, Zhang Mingzhi
Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450002, P.R. China.
Lymphoma Diagnosis and Treatment Center, Zhengzhou, Henan 450002, P.R. China.
Oncol Lett. 2018 Nov;16(5):6624-6632. doi: 10.3892/ol.2018.9447. Epub 2018 Sep 18.
The present study reports two cases of concurrently diagnosed T-lymphoblastic lymphoma (T-LBL) and chronic myeloid leukemia (CML). The literature review revealed that myeloid leukemia may appear secondary to Hodgkin lymphoma or non-Hodgkin lymphoma. However, simultaneous bi-lineage hematologic malignancies are rarely seen and the prognosis is worse than single lineage lymphoma or myeloid leukemia. There were no standard therapies. All simultaneous bi-lineage malignancies of myeloid leukemia and lymphoma reported in Pubmed were combined with the present two cases, to analyses its pathogenesis, features and treatment. It was concluded that the prognosis of bi-lineage hematologic malignancies was poor, however allogeneic hematopoietic stem cell transplantation could improve survival (P=0.033).
本研究报告了两例同时诊断为T淋巴细胞母细胞淋巴瘤(T-LBL)和慢性粒细胞白血病(CML)的病例。文献回顾显示,髓系白血病可能继发于霍奇金淋巴瘤或非霍奇金淋巴瘤。然而,同时发生的双谱系血液系统恶性肿瘤很少见,且预后比单谱系淋巴瘤或髓系白血病更差。目前尚无标准治疗方法。将PubMed报道的所有髓系白血病与淋巴瘤同时发生的双谱系恶性肿瘤病例与本两例病例相结合,分析其发病机制、特征及治疗方法。得出的结论是,双谱系血液系统恶性肿瘤预后较差,而异基因造血干细胞移植可提高生存率(P=0.033)。